dacarbazine and Cancer, Second Primary

dacarbazine has been researched along with Cancer, Second Primary in 86 studies

Research

Studies (86)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (20.93)18.2507
2000's28 (32.56)29.6817
2010's33 (38.37)24.3611
2020's7 (8.14)2.80

Authors

AuthorsStudies
Googe, PB; Li, H; McKenna, EF; Moschos, SJ; Pergaris, A; Theocharis, S; Yan, Y1
Hagelstein, V; Klee, G; Kurzhals, JK; Langan, EA; Terheyden, P; Zillikens, D1
Cutter, DJ; Daly, P; Duane, FK; Gillham, C; Houlihan, OA; McArdle, O; Ntentas, G1
Bloudek, B; Burke, JM; Fanale, M; Liu, N; Migliaccio-Walle, K; Phillips, T; Yu, KS1
Charpentier, C; Dreno, B; Flet, L; Fronteau, C; Guile, R; Khammari, A; Nguyen, JM; Poinas, A; Riche, VP; Thomare, P; Varey, É1
André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL1
Cui, F; Yan, J; Zhao, S1
Borchmann, P; Borchmann, S; Bröckelmann, PJ; Buerkle, C; Diehl, V; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Müller, H; Plütschow, A; Sasse, S1
Becker, I; Eichenauer, DA; Engert, A; Franklin, J; Monsef, I1
Miyakita, Y; Momota, H; Narita, Y; Shibui, S1
Bartlett, NL1
Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB1
Hochhaus, A; Kunert, C; Schnetzke, U; Scholl, S; Schrenk, K; Spies-Weisshart, B1
Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D1
Bochenek-Cibor, J; Krupa, M; Moskała, M; Trojanowski, T1
Bayman, E; Gilson, D; Murray, L; Prestwich, RJ; Robertshaw, H; Sethugavalar, B; Thomas, E1
Beaven, AW; Diehl, LF; Kelsey, CR; Kim, GJ; Prosnitz, LR; Torok, JA; Wu, Y1
Almagro-Casado, E; Cantos, B; Pérez-Callejo, D; Provencio, M; Salas, C; Sánchez, A1
Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A1
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C1
Ajit, NE; Burton, GV; El-Osta, H; Peddi, P1
Campanelli, M; Caputo, MD; Del Poeta, G; Foà, R; Frustaci, AM; Galieni, P; Gentile, M; Gozzetti, A; Guarini, A; Innocenti, I; Laurenti, L; Mauro, FR; Morabito, F; Motta, M; Murru, R; Raponi, S; Reda, G; Tedeschi, A1
Camci, C; Comez, G; Kalender, ME; Pehlivan, Y; Sari, I; Sevinc, A1
Bourgeois, JM; Hodson, I; Macdonald, P; Midia, M; Mullah-Ali, A; Portwine, C; Ramsay, JA1
Cordera, S; Joosens, E; Nader, P; Neyns, B; Pouratian, N1
Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA1
Davies, SM; Geiger, H; Weiss, B1
Das, P; Dwary, A; Goyal, S; Gupta, D; Mohanti, BK; Muzumder, S; Sharma, A; Thulkar, S1
Nishikawa, R1
Leong, C; Lim, ST; Loh, Y; Ngeow, J; Quek, R; Tan, HC; Tan, I; Tao, M1
Cheson, BD1
de Juan, M; Díaz, R; Fonfría, M; Mancheño, N; Moral, P; Tormo, A1
Hosono, A; Makimoto, A; Miyakita, Y; Momota, H; Nariata, Y; Narita, Y; Shibui, S1
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M1
Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O1
Chen, DB; Shen, DH; Wang, Y1
Fukushima, T; Inoue, T; Kawaguchi, H; Komatsu, F; Komatsu, M; Nabeshima, K; Oshiro, S; Tsugu, H1
Ichikawa, M; Kurokawa, M; Nakamura, F; Nannya, Y; Ogura, M; Tanaka, M; Todo, T1
Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D1
Chen, BE; Connors, JM; Crump, M; Dar, AR; Djurfeldt, MS; Gospodarowicz, MK; Horning, SJ; Meyer, RM; Pearcey, RG; Shepherd, LE; Shustik, C; Stewart, DA; Wells, WA; Winter, JN1
Abo-Madyan, Y; Giordano, FA; Welzel, G; Wenz, F1
Hoshimaru, M; Kawanabe, Y; Kihara, S; Koizumi, T; Sasaki, N; Sawada, M; Ueda, S; Yukawa, H1
Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A1
Hewer, E; Kappeler, A; Reinert, MM; Vajtai, I; Vassella, E1
Goto, Y; Hashimoto, N; Kagawa, N; Khoo, HM; Kinoshita, M; Kishima, H; Maruno, M; Yoshimine, T1
Chim, CS; Choi, PT; Lee, WK1
Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA1
Dixit, S; Hingorani, M; Rajaraman, C; Rowland-Hill, C; Salvage, D1
Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL1
Diehl, V; Dörken, B; Dühmke, E; Franklin, J; Hasenclever, D; Herrmann, R; Lathan, B; Loeffler, M; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Tesch, H1
Longo, DL1
Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K1
Anargyrou, K; Angelopoulou, MK; Boussiotis, VA; Boutsis, DE; Dimopoulou, MN; Karkantaris, C; Kokoris, SI; Kontopidou, FN; Kyrtsonis, MC; Michalopoulos, T; Panayiotidis, P; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Tsaftaridis, P; Variamis, E; Vassilakopoulos, TP1
Bonadonna, G; Bonfante, V; Gianni, AM; Valagussa, P; Viviani, S1
Bouffet, E; Foreman, N; Korones, DN; Smith, A1
Alpert, TE; Hatoum, GF; Morbidini-Gaffney, S; Sagerman, RH1
Baehring, J; Ballen, KK; Berliner, N; Henson, JW; Kracher, J; Lacy, J; Noronha, V1
Connors, JM; Foltz, LM; Song, KW1
Arora, B; Biswas, G; Deshmukh, C; Khadwal, A; Kurkure, PA; Shetty, V1
Arcaini, L; Baio, A; Brusamolino, E; Casagrande, W; Franchini, P; Griva, V; Lazzarino, M; Orlandi, E; Pascutto, C; Passamonti, F1
Doherty, LM; Drappatz, J; Kesari, S; Monje, ML; Ramakrishna, NR; Wen, PY; Young, G1
Diehl, V; Fuchs, M1
Beard, J; Elmahy, H; Hawley, I1
Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M1
Crippa, C; Facchetti, F; Ferrari, S; Frata, P; Grazioli, L; Magrini, SM; Pizzocaro, C; Re, A; Rossi, G; Tucci, A1
Alessandrino, EP; Astori, C; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Livraghi, A; Morra, E; Orlandi, E; Pagnucco, G1
Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R1
Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G1
Prosnitz, LR; Wu, JJ; Yahalom, J1
Cooper, DL; Levy, A; Salloum, E; Tallini, G1
Goldberg, SL; Klumpp, TR; Mangan, KF; Ming, PL; Mullaney, MT; Rao, PN; Redei, I1
André, M; Brice, P; Cazals, D; Fermé, C; Gisselbrecht, C; Hennequin, C; Kerneis, Y; Lepage, E; Rousselot, P; Zini, JM1
Behrendt, H; van den Berg, H; Zsiros, J1
Andrieu, JM; Colonna, P1
Aviles, A; Delgado, S1
Acevedo, A; Arranz, R; Fernández-Rañada, JM; Gil-Fernández, JJ; Muñoz, E; Sobrino, MP1
Joensuu, H; Muhonen, T; Nyandoto, P1
Bonadonna, G; Valagussa, P1
Aisenberg, AC1
Calvo Villas, J; Ramírez Sánchez, M; Sicilia Guillén, F1
Bosković, D; Colović, M; Elezović, I; Tomin, D1
el Omri, H; Ennabli, S; Korbi, S; Kraiem, I; Skouri, H; Sriha, B; Youssef, YB1
Ebsen, M; Kirchner, EM; Kirchner, J; Theegarten, D; Voigtmann, R1
Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF1
Kiss, A; Rák, K; Telek, B; Ujj, G1
Bruce-Gregorios, JH; Feun, LG; Green, B; Nadeem, SQ1

Reviews

14 review(s) available for dacarbazine and Cancer, Second Primary

ArticleYear
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
    Cancer medicine, 2020, Volume: 9, Issue:18

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult

2020
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
    The Cochrane database of systematic reviews, 2017, 09-13, Volume: 9

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Vinblastine

2017
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2013

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2013
Astrocytoma malignum in glioblastoma multiforme vertens with long term survival--case report and a literature review.
    Przeglad lekarski, 2014, Volume: 71, Issue:8

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Craniotomy; Dacarbazine; Frontal Lobe; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Prognosis; Remission Induction; Temozolomide

2014
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lumbar Vertebrae; Mechlorethamine; Muscle Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Remission Induction; Retroperitoneal Neoplasms; Sarcoma, Synovial; Spinal Stenosis; Translocation, Genetic; Vincristine

2008
[Treatment of glioma with temozolomide].
    Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:7

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Dacarbazine; DNA Damage; Glioblastoma; Humans; Leukemia, Myeloid, Acute; Lomustine; Myelodysplastic Syndromes; Neoplasms, Second Primary; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide

2009
Is BEACOPP better than ABVD?
    Current hematologic malignancy reports, 2007, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Forecasting; Hodgkin Disease; Humans; Infertility; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Patient Selection; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

2007
Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
    British journal of haematology, 2011, Volume: 154, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Glioma; Humans; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide

2011
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature.
    Neuro-oncology, 2006, Volume: 8, Issue:3

    Topics: Aged; Breast Neoplasms; Dacarbazine; Female; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide

2006
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2007, Volume: 37, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine

2007
The case for adjuvant radiation therapy in advanced Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Vinblastine

1996
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine

1996
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Sangre, 1998, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prednisone; Procarbazine; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Salvage Therapy; Spain; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

1998
Problems in Hodgkin's disease management.
    Blood, 1999, Feb-01, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cardiomyopathies; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infections; Laparotomy; Lung Diseases, Interstitial; Lymphography; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiation Injuries; Radiotherapy; Remission Induction; Salvage Therapy; Vinblastine; Vincristine

1999

Trials

16 trial(s) available for dacarbazine and Cancer, Second Primary

ArticleYear
Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
    Current problems in cancer, 2022, Volume: 46, Issue:3

    Topics: Dacarbazine; Humans; Ki-67 Antigen; Lymphocytes, Tumor-Infiltrating; Melanoma; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Vemurafenib

2022
Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Neoplasms, Second Primary; United States; Vinblastine

2023
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jun-20, Volume: 35, Issue:18

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Vinblastine; Vincristine; Young Adult

2017
Secondary hematological malignancies associated with temozolomide in patients with glioma.
    Neuro-oncology, 2013, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Female; Follow-Up Studies; Glioma; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Temozolomide; Young Adult

2013
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
    Klinische Padiatrie, 2014, Volume: 226, Issue:6-7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult

2014
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2016
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
    The New England journal of medicine, 2012, Feb-02, Volume: 366, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Radiotherapy; Survival Analysis; Treatment Outcome; Vinblastine

2012
ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2012, Volume: 188, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Chemoradiotherapy; Cohort Studies; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Lymphatic Irradiation; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Risk Factors; United States; Vinblastine

2012
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine

2003
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
    Surgical neurology, 2008, Volume: 69, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome

2008
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Combined Modality Therapy; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Gallium; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Risk; Tomography, X-Ray Computed; Vinblastine

2008
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
    International journal of radiation oncology, biology, physics, 1994, Nov-15, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine

1994
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).
    Hematology and cell therapy, 1997, Volume: 39, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Gonads; Heart; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prospective Studies; Radiotherapy; Survival Rate; Thyroid Gland; Treatment Outcome; Vinblastine; Vindesine

1997
Treatment of childhood Hodgkin's disease without radiotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine

1997
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasms, Second Primary; Oligospermia; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

1998
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
    Clinical and laboratory haematology, 1998, Volume: 20, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine

1998

Other Studies

56 other study(ies) available for dacarbazine and Cancer, Second Primary

ArticleYear
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?
    Melanoma research, 2022, 10-01, Volume: 32, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Immune Checkpoint Inhibitors; Male; Melanoma; Neoplasms, Second Primary; Retrospective Studies; Skin Neoplasms; Tumor Microenvironment

2022
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breath Holding; Cardiovascular Diseases; Dacarbazine; Doxorubicin; Female; Heart; Hodgkin Disease; Humans; Lymphoma; Mediastinal Neoplasms; Neoplasms, Second Primary; Organs at Risk; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Vinblastine

2023
Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
    European journal of dermatology : EJD, 2023, Apr-01, Volume: 33, Issue:2

    Topics: Cost-Benefit Analysis; Cost-Effectiveness Analysis; Dacarbazine; Female; Humans; Male; Melanoma; Neoplasms, Second Primary; Retrospective Studies

2023
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
    International journal of laboratory hematology, 2022, Volume: 44, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine

2022
Thyroid malignancies in survivors of Hodgkin lymphoma.
    International journal of radiation oncology, biology, physics, 2014, Mar-01, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Databases, Factual; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Poisson Distribution; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Survivors; Thyroid Neoplasms; Vinblastine; Vincristine; Young Adult

2014
Different clones of acute leukemia after successful treatment of Hodgkin's disease.
    Annals of hematology, 2014, Volume: 93, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Azacitidine; Bleomycin; Bone Marrow; Clone Cells; Consolidation Chemotherapy; Dacarbazine; Doxorubicin; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Palliative Care; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vinblastine

2014
Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2015, Volume: 27, Issue:7

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Humans; Lymphatic Irradiation; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Organs at Risk; Radiotherapy; Radiotherapy Dosage; Risk Assessment; Vinblastine; Young Adult

2015
Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
    International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Hypothyroidism; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiotherapy Dosage; Retrospective Studies; Vinblastine; Young Adult

2015
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Vinblastine; Vincristine; Young Adult

2016
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
    Acta haematologica, 2016, Volume: 135, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2016
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.
    BMJ case reports, 2016, Dec-23, Volume: 2016

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cognition Disorders; Dacarbazine; Dexamethasone; Glioblastoma; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary; Piracetam; Temozolomide

2016
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
    American journal of hematology, 2017, Volume: 92, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine

2017
Synchronous Hodgkin's disease and gastric adenocarcinoma.
    Oncology, 2007, Volume: 73, Issue:5-6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Radiography; Reed-Sternberg Cells; Stomach Neoplasms; Treatment Outcome; Vinblastine

2007
Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Glioma; Humans; Lymphoma, Non-Hodgkin; Mice; Middle Aged; Neoplasms, Second Primary; Risk Assessment; Temozolomide

2008
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Annals of hematology, 2009, Volume: 88, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hodgkin Disease; Hospitals, Urban; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Vinblastine; Vincristine; Young Adult

2009
Possible leukemogenic potential of temozolomide.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:4

    Topics: Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Dacarbazine; DNA; Mice; Mice, Transgenic; Mutation; Neoplasms, Second Primary; Polymerase Chain Reaction; Temozolomide

2009
Non-Hodgkin lymphoma following temozolomide.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:4

    Topics: Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Glioblastoma; Humans; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Temozolomide

2009
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Vinblastine

2010
Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2010, Volume: 12, Issue:4

    Topics: Adenocarcinoma, Follicular; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Female; Humans; Hypertension; Immunotherapy; Interferons; Melanoma; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Thyroid Neoplasms

2010
Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
    Pediatric blood & cancer, 2010, Volume: 55, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Child; Dacarbazine; Female; Frontal Lobe; Genes, p53; Germ-Line Mutation; Humans; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide

2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3

    Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2011
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:7

    Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Hyperparathyroidism, Primary; Male; Mechlorethamine; Neoplasms, Second Primary; Parathyroid Neoplasms; Prednisone; Procarbazine; Vinblastine; Vincristine

2010
[Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2010, Volume: 39, Issue:9

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD79 Antigens; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Second Primary; Prednisone; Rituximab; Vinblastine; Vincristine

2010
Radiation-induced astrocytoma with rapid malignant transformation: case report.
    Neurologia medico-chirurgica, 2011, Volume: 51, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Basal Ganglia; Brain Neoplasms; Cell Transformation, Neoplastic; Cerebellar Neoplasms; Dacarbazine; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hydrocephalus; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide; Time Factors; Young Adult

2011
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Confidence Intervals; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymph Node Excision; Mastectomy, Segmental; Mechlorethamine; Mediastinum; Middle Aged; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2012
Radiation-induced spinal cord anaplastic astrocytoma subsequent to radiotherapy for testicular seminoma.
    Neurologia medico-chirurgica, 2012, Volume: 52, Issue:9

    Topics: Antineoplastic Agents; Astrocytoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease Progression; Fatal Outcome; Humans; Hydrocephalus; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Nimustine; Seminoma; Spinal Cord Compression; Spinal Cord Neoplasms; Syringomyelia; Temozolomide; Testicular Neoplasms; Thoracic Vertebrae; Time Factors

2012
[A silent-growing and fast-killing melanoma in a teenager].
    Annales de pathologie, 2012, Volume: 32, Issue:4

    Topics: Adolescent; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Back Pain; Combined Modality Therapy; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gene Amplification; Head and Neck Neoplasms; Humans; Immunotherapy; In Situ Hybridization, Fluorescence; Ipilimumab; Lymphatic Metastasis; Melanoma; Nausea; Neoplasm Proteins; Neoplasms, Second Primary; Nevus; Osteolysis; Scalp; Skin Neoplasms; Weight Loss

2012
Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
    Pathology, research and practice, 2012, Dec-15, Volume: 208, Issue:12

    Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; Disease Progression; Gliosarcoma; Humans; Isocitrate Dehydrogenase; Male; Mutation; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Temozolomide

2012
Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report.
    British journal of neurosurgery, 2013, Volume: 27, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Dacarbazine; Ependymoma; Female; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide

2013
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
    Annals of hematology, 2013, Volume: 92, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Combined Modality Therapy; Dacarbazine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Salvage Therapy; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine

2013
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-10, Volume: 31, Issue:5

    Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; California; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dacarbazine; Databases, Factual; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Melphalan; Methotrexate; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Vinblastine; Vincristine

2013
Hypernatremia-associated myelinolysis following the management of sepsis in a patient with glioblastoma treated with radiotherapy and temozolomide.
    Acta neurologica Belgica, 2013, Volume: 113, Issue:4

    Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Dacarbazine; Diabetes Mellitus; Fatal Outcome; Glioblastoma; Humans; Hypernatremia; Hypertension; Liver Diseases; Male; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Conformal; Sepsis; Temozolomide; Thyroid Cancer, Papillary; Thyroid Neoplasms

2013
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
    Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2

    Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor

2002
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
    Journal of the National Cancer Institute, 2003, Jul-02, Volume: 95, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Incidence; Mechlorethamine; Menopause, Premature; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Vinblastine; Vincristine

2003
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2003, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Tunisia; Vinblastine; Vincristine

2003
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Vincristine

2004
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disease Progression; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2005
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Pediatric blood & cancer, 2006, Volume: 47, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Etoposide; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome

2006
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
    American journal of clinical oncology, 2005, Volume: 28, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Goiter, Nodular; Hodgkin Disease; Humans; Mechlorethamine; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neurilemmoma; Pleural Neoplasms; Prednisone; Procarbazine; Radiotherapy; Recurrence; Skin Neoplasms; Vinblastine; Vincristine

2005
Hodgkin's lymphoma in adolescents.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-01, Volume: 24, Issue:16

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Mechlorethamine; Medical Record Linkage; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Registries; Risk Assessment; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2006
Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease.
    Indian journal of pediatrics, 2006, Volume: 73, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Dacarbazine; Dose Fractionation, Radiation; Doxorubicin; Femur; Hodgkin Disease; Humans; Male; Mediastinum; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive; Vinblastine

2006
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-01, Volume: 12, Issue:21

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fertility; Follow-Up Studies; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Pregnancy; Radiotherapy, Adjuvant; Survival Analysis; Vinblastine

2006
Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide.
    Journal of neuro-oncology, 2007, Volume: 84, Issue:2

    Topics: Aged; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Dacarbazine; Diagnosis, Differential; Female; Glioma; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiotherapy; Temozolomide

2007
Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    International journal of laboratory hematology, 2007, Volume: 29, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Cells; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymph Nodes; Lymphocytes; Lymphocytosis; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasms, Second Primary; Splenectomy; Splenic Neoplasms; Splenomegaly; Vinblastine

2007
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Multivariate Analysis; Myocardial Infarction; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy; Regression Analysis; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1994
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Patient Compliance; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1995
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Chromosome Deletion; Chromosomes, Human, Pair 20; Clone Cells; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Hematopoietic Cell Growth Factors; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm, Residual; Neoplasms, Second Primary; Neoplastic Stem Cells; Prednisone; Procarbazine; Radiotherapy; Recurrence; Transplantation, Autologous; Vinblastine; Vincristine

1997
Second cancer among long-term survivors from Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1998, Sep-01, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy Dosage; Survivors; Time Factors; Vinblastine; Vincristine

1998
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Susceptibility; Doxorubicin; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Mechlorethamine; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Splenectomy; Vinblastine; Vincristine; Whole-Body Irradiation

1998
[Chronic lymphatic leukemia and Hodgkin's disease].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neoplasms, Second Primary; Prednisone; Remission Induction; Vidarabine; Vinblastine

1999
Pregnancy after treatment of secondary acute promyelocytic leukemia following Hodgkin's disease: a case report.
    Medical oncology (Northwood, London, England), 2000, Volume: 17, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia, Promyelocytic, Acute; Neoplasms, Second Primary; Pregnancy; Pregnancy Outcome; Treatment Outcome; Tretinoin; Vinblastine

2000
[Gastric adenocarcinoma secondary to Hodgkin's disease treatment].
    La Tunisie medicale, 2001, Volume: 79, Issue:4

    Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Deglutition Disorders; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Stomach Neoplasms; Tomography, X-Ray Computed; Vinblastine; Weight Loss

2001
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Rituximab; Vinblastine; Vincristine

2001
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine

1992
[Secondary acute leukemia in Hodgkin's disease].
    Orvosi hetilap, 1992, Sep-13, Volume: 133, Issue:37

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vinblastine; Vincristine

1992
Post radiation sarcoma (malignant fibrous histiocytoma) of the cervical spine following ependymoma (a case report).
    Journal of neuro-oncology, 1991, Volume: 11, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cervical Vertebrae; Combined Modality Therapy; Dacarbazine; Dexamethasone; Diagnostic Errors; Doxorubicin; Ependymoma; Histiocytoma, Benign Fibrous; Humans; Laminectomy; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, High-Energy; Spinal Cord Neoplasms; Spinal Neoplasms

1991